Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8786678 | European Journal of Surgical Oncology (EJSO) | 2018 | 26 Pages |
Abstract
Despite a more advanced clinical stage, complete pathologic response was more common in patients treated with CRT than in patients treated with RT. Prospective trials are needed to establish the differences in other outcome parameters, including the impact on organ preserving strategies.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
A.J.M. Rombouts, N. Hugen, R.H.A. Verhoeven, M.A.G. Elferink, P.M.P. Poortmans, I.D. Nagtegaal, J.H.W. de Wilt,